International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.8054805
Original Article
Cross Sectional Study of Clinical Profile, Laboratory Parameters and 2d Echo Findings in Patients with Metabolic Syndrome
 ,
 ,
Published
June 19, 2023
Abstract
Background: Metabolic syndrome is a cluster of risk factors associated with increased cardiovascular morbidity and mortality. Left ventricular diastolic dysfunction (LVDD) is an early manifestation of metabolic disease-related cardiomyopathy. This study aimed to investigate the association between metabolic syndrome and LVDD, as well as potential sex differences and specific risk factors. Methods: A cross-sectional study was conducted, including [insert number] participants with metabolic syndrome. Demographic data, clinical measurements, and echocardiographic findings were recorded. Statistical analysis was performed to assess associations and correlations. Results: Among the study population, [insert percentage] % were found to have LVDD. Metabolic syndrome showed a dose-dependent association with the risk of LVDD, with a stronger association observed in men compared to women. Waist circumference and triglyceride levels were identified as independent risk factors for LVDD in men. However, no significant correlations were found between LVDD and blood pressure, fasting blood sugar, waist measurement, triglycerides, or high-density lipoprotein levels. Conclusion: This study provides evidence of an association between metabolic syndrome and the risk of LVDD, emphasizing the importance of early detection to prevent disease progression and cardiac failure. Sex differences were observed, with men showing a stronger association between metabolic syndrome and LVDD. Waist circumference and triglyceride levels were identified as significant risk factors for LVDD in men. These findings highlight the need for comprehensive risk assessment and targeted interventions in individuals with metabolic syndrome to mitigate the risk of LVDD.
Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
1903 Views
491 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved